<code id='B4E2925747'></code><style id='B4E2925747'></style>
    • <acronym id='B4E2925747'></acronym>
      <center id='B4E2925747'><center id='B4E2925747'><tfoot id='B4E2925747'></tfoot></center><abbr id='B4E2925747'><dir id='B4E2925747'><tfoot id='B4E2925747'></tfoot><noframes id='B4E2925747'>

    • <optgroup id='B4E2925747'><strike id='B4E2925747'><sup id='B4E2925747'></sup></strike><code id='B4E2925747'></code></optgroup>
        1. <b id='B4E2925747'><label id='B4E2925747'><select id='B4E2925747'><dt id='B4E2925747'><span id='B4E2925747'></span></dt></select></label></b><u id='B4E2925747'></u>
          <i id='B4E2925747'><strike id='B4E2925747'><tt id='B4E2925747'><pre id='B4E2925747'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:87173
          Adobe

          UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

          “Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

          advertisement

          Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Why the world’s most expensive drug might be worth the price
          Why the world’s most expensive drug might be worth the price

          AdobeThestaffoftheInstituteforClinicalandEconomicReview,orICER,areknownasthenerdsofthedrugindustry:b

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          PBM reform efforts get punted in Congress

          LawmakersinCongresshavedecidedtopunteffortstoreformhowPBMsoperate.BRENDANSMIALOWSKI/AFP/GettyImagesW